Q3-2025 Earnings October 22, 2025 © 2025 Texas Capital Bank Member FDIC Forward-Looking Statements This communication contains "forward-looking statements" within the meaning of and pursuant to the Private Securities Litigation Reform Act of 1995 regarding, among other things, TCBI's financial condition, results of operations, business plans and future performance. These statements are not historical in nature and may often be identified by the use of words such as "believes," "projects," "expects," "may," ...

October 22, 2025 3 rd Quarter Earnings Alcoa Corporation 1 Cautionary Statement regarding Forward-Looking Statements This presentation contains statements that relate to future events and expectations and as such constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include those containing such words as "aims," "ambition," "anticipates," "believes," "could," "develop," "endeavors," "estimates," "expects," "forecasts," "g ...

Ribbon Communications Third Quarter 2025 Results October 22, 2025 © 2025 Ribbon | Public 1 Note Regarding Forward-Looking Statements and Non-GAAP Financial Measures This presentation contains "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, which are subject to a number of risks and uncertainties. All statements other than statements of historical facts contained in this release, including without limitation, statements regarding our projected fin ...

3Q25 Earnings Presentation October 22, 2025 Singapore: 3 Forward Looking Statements This presentation contains forward-looking statements made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include the discussions of our business strategies and expectations concerning future operations, margins, profitability, liquidity and capital resources. In addition, in certain portions included in this presentation, the words "anticipate ...

Phase 2 Trial of VTX3232 in Participants with Obesity and Cardiovascular Risk Factors Topline Results October 22, 2025 Forward Looking Statements Ventyx Biosciences, Inc. ("Ventyx" or the "Company") cautions you that statements contained in this presentation regarding matters that are not historical facts are forward-looking statements. These statements are based on the Company's current beliefs and expectations. Such forward-looking statements include, but are not limited to, statements regarding: the pote ...

Third Quarter 2025 Earnings Disclosure This presentation, including documents incorporated herein by reference, will contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could ca ...

October 22, 2025 Third Quarter 2025 Earnings Conference Call The pathway to possible. Cautionary Language PAGE 3 Third Quarter 2025 Earnings Conference Call v Delivered strong third quarter results, highlighted by 5.2% organic growth, excluding the impact of Sprint Cancellations.(1) V Increased full year 2025 Outlook as we continue to find opportunities to operate more efficiently, and demand for our assets remains strong. v We anticipate generating long-term attractive risk- adjusted returns as the only la ...

Q3 2025 Earnings Supplemental Materials | | | Q3 | | | --- | --- | --- | --- | | | 2025 | | 2024 | | Results Operating | | | | | Revenues | $ 1,011.4 | $ | 1,031.0 | | Gross Profit | | 296.9 | 300.4 | | Net Income | | 38.1 | 47.5 | | Adjusted Net Income | | 57.3 | 64.3 | | Adjusted EBITDA | | 112.6 | 116.9 | | Margins | | | | | Gross | | 29.4% | 29.1% | | EBITDA Adjusted | | 11.1% | 11.3% | | Earnings per Share - Diluted | | | | | Income per Share | $ | 0.87 $ | 1.06 | | Net Income Adjusted | $ | 1.31 $ | 1 ...

EARNINGS CALL 3rd Quarter 2025 October 22, 2025 Forward-Looking Statements This presentation contains forward-looking statements that relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts. Examples of forward-looking statements include, among others, statements we make regarding our expectations with regard to our business, financial and operating results, future economic performance an ...

Q3 2025 Performance Highlights - Adjusted diluted earnings per share (EPS) for Q3 2025 increased by approximately 63% compared to Q3 2024, primarily driven by higher adjusted operating profit resulting from a 28% increase in organic net sales and benefits from lower income taxes[6] - Organic net sales in Q3 2025 increased by 28% compared to Q3 2024, driven by strong performance in the Americas (up 43%) and APAC (up 21%), while EMEA experienced a 4% decline[6] - The book-to-bill ratio for Q3 2025 was approximately 1.4x, with trailing twelve-month (TTM) organic orders growth of approximately 21%[7] - Adjusted operating margin for Q3 2025 reached 22.3%, exceeding both guidance and the prior year's figures, contributing to an adjusted operating profit of $596 million, a 43% increase from the previous year's quarter[7] Full Year 2025 Guidance - The company raised its full-year adjusted free cash flow guidance to $1,500 million[8] - The company raised its full-year adjusted diluted EPS guidance to $4.10, a 44% increase from 2024, and adjusted operating profit guidance to $2,060 million, a 33% increase from 2024, primarily driven by a $2.2 billion increase in projected net sales, a 27% increase from 2024[9] - The company expects full-year 2025 adjusted operating margin to be approximately 20.2%, about 80 bps higher than full-year 2024[9] Orders and Backlog - Strong backlog at the end of the third quarter of $9.5 billion, up approximately $2.2 billion or approximately 30% versus the same prior year period and up 12% versus the end of the second quarter 2025[15] - Third quarter orders up approximately 60% from third quarter 2024 and up approximately 20% sequentially[15] Regional Performance - Americas net sales increased by 42.9% to $1,712.4 million in Q3 2025 from $1,198.6 million in Q3 2024, with organic growth of 43%[46] - APAC net sales increased by 20.2% to $519.8 million in Q3 2025 from $432.4 million in Q3 2024, with organic growth of 21.3%[46] - EMEA net sales increased by 0.2% to $443.6 million in Q3 2025 from $442.5 million in Q3 2024, but experienced a 4% decline in organic net sales[46]